US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagonist Therapeutics

42.97

-0.9500-2.16%

Post-market: 42.970.00000.00%16:08 EDT

Volume:671.23K

Turnover:29.31M

Market Cap:2.66B

PE:49.82

High:45.43

Open:44.15

Low:42.85

Close:43.92

Loading ...

Overview Company News Filings

PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study

Wedbush Adjusts Protagonist Therapeutics Price Target to $70 From $58, Maintains Outperform Rating

MT Newswires Live

Protagonist Therapeutics Inc : Wedbush Raises Target Price to $70 From $58

THOMSON REUTERS

Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success

Why Protagonist Therapeutics, Inc. (PTGX) Went Up on Monday

Protagonist Therapeutics price target raised to $80 from $54 at H.C. Wainwright

Top Midday Gainers

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group

Protagonist Therapeutics Inc : Btig Raises Target Price to $82 From $73

THOMSON REUTERS

Truist Securities Adjusts Price Target on Protagonist Therapeutics to $76 From $60, Keeps Buy Rating

MT Newswires Live

Protagonist Therapeutics Shares Rise After Positive Trial Data for Icotronkinra

BUZZ-Protagonist Therapeutics rises as bowel disease drug succeeds mid-stage study

Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out

Protagonist Reports Positive Top Line Results From Phase 2B Study of Icotrokinra

THOMSON REUTERS

Protagonist : Results From Phase 2B Study of Icotrokinra Showing Potential to Transform Treatment Paradigm for Patients With Ulcerative Colitis

THOMSON REUTERS

Protagonist Therapeutics : All Three Doses Met the Primary Endpoint of Clinical Response at Week 12, With a Favorable Safety Profile

THOMSON REUTERS

Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis

ACCESS Newswire

Protagonist Therapeutics Price Target Maintained With a $54.00/Share by HC Wainwright & Co.

Protagonist Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Market Potential of Icotrokinra

Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), Halozyme (HALO) and Arcturus Therapeutics (ARCT)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PTGX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PTGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTGX\",,,,,undefined,":{"symbol":"PTGX","market":"US","secType":"STK","nameCN":"Protagonist Therapeutics","latestPrice":42.97,"timestamp":1746820800000,"preClose":43.92,"halted":0,"volume":671228,"hourTrading":{"tag":"盘后","latestPrice":42.97,"preClose":42.97,"latestTime":"16:08 EDT","volume":5207,"amount":223743.34,"timestamp":1746821309591},"delay":0,"floatShares":46451768,"shares":61981955,"eps":0.862523,"marketStatus":"Market Closed","change":-0.95,"latestTime":"05-09 16:00:00 EDT","open":44.15,"high":45.43,"low":42.85,"amount":29313452.885121,"amplitude":0.058743,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.862523,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":43.92,"preHourTrading":{"tag":"盘前","latestPrice":44.6,"preClose":43.92,"latestTime":"08:50 EDT","volume":85,"amount":3806.8304,"timestamp":1746795049667},"postHourTrading":{"tag":"盘后","latestPrice":42.97,"preClose":42.97,"latestTime":"16:08 EDT","volume":5207,"amount":223743.34,"timestamp":1746821309591},"volumeRatio":0.7007102432150989,"impliedVol":0.4055,"impliedVolPercentile":0.124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTGX\",,,,,undefined,":{"symbol":"PTGX","floatShares":46451768,"roa":"2.48%","roe":"8.99%","lyrEps":4.469732,"volumeRatio":0.7007102432150989,"shares":61981955,"dividePrice":0,"high":45.43,"amplitude":0.058743,"preClose":43.92,"low":42.85,"week52Low":27,"pbRate":"3.87","psRate":"12.82","week52High":60.6,"institutionHeld":0,"latestPrice":42.97,"eps":0.862523,"divideRate":0,"volume":671228,"delay":0,"ttmEps":0.862523,"open":44.15,"prevYearClose":38.6,"prevWeekClose":45.51,"prevMonthClose":45.82,"prevQuarterClose":48.36,"fiveDayClose":45.51,"twentyDayClose":40.89,"sixtyDayClose":37.42},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTGX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518727781","title":"PTGX Up as J&J-Partnered Drug Meets Goal in Ulcerative Colitis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518727781","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518727781?lang=en_us&edition=fundamental","pubTime":"2025-03-12 00:15","pubTimestamp":1741709700,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics, Inc. PTGX announced positive top-line data from the phase IIb ANTHEM-UC study, which evaluated icotrokinra , an investigational targeted oral peptide that selectively blocks the IL-23 receptor, for treating adults with moderately to severely active ulcerative colitis , a chronic disease of the large intestine.The ANTHEM-UC study, conducted by Protagonist's partner, Johnson & Johnson JNJ, met its primary endpoint of clinical response in all icotrokinra dose groups.Treatment with icotrokinra also demonstrated clinically meaningful differences in key secondary endpoints of clinical remission, symptomatic remission and endoscopic improvement at week 12 versus placebo in the ANTHEM-UC study.Shares of PTGX were up 45.9% on March 10 following the announcement of the news.In the past year, shares of Protagonist have rallied 87.4% against the industry’s decline of 8.5%.The randomized, placebo-controlled phase IIb ANTHEM-UC study evaluated the safety and efficacy of thr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ptgx-j-j-partnered-drug-161500020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550221.USD","LU2430703178.SGD","IE00BGHQF631.EUR","LU1585245621.USD","LU1023059063.AUD","SG9999002232.USD","LU1061106388.HKD","JNJ","LU2125154778.USD","IE00B4R5TH58.HKD","LU0640476718.USD","IE00B42XCP33.USD","BK4581","LU2125154935.USD","LU1989771016.USD","LU0792757196.USD","LU1066051498.USD","BK4585","LU1868836591.USD","BK4588","LU0203347892.USD","IE00BFXG1179.USD","LU1323610961.USD","LU2133065610.SGD","LU2347655156.SGD","BK4534","LU2360032135.SGD","LU1929549753.HKD","LU0345770993.USD","LU1291159041.SGD","LU2602419157.SGD","BK4532","LU2468319806.SGD","LU2129689431.USD","IE00B2B36J28.USD","IE000M9KFDE8.USD","IE0034235303.USD","IE00BVYPNV92.GBP","LU1244550577.SGD","BK4007","BMY","LU1221951046.USD","BK4592","BMRN","LU1674673428.USD","LU1914381329.SGD","PTGX","LU0098860793.USD","LU0795875086.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2518725302","title":"Wedbush Adjusts Protagonist Therapeutics Price Target to $70 From $58, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2518725302","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518725302?lang=en_us&edition=fundamental","pubTime":"2025-03-11 23:11","pubTimestamp":1741705880,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) has an average rating of Buy and mean price target of $66.82, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTGX"],"gpt_icon":0},{"id":"2518231787","title":"Protagonist Therapeutics Inc : Wedbush Raises Target Price to $70 From $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2518231787","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518231787?lang=en_us&edition=fundamental","pubTime":"2025-03-11 23:00","pubTimestamp":1741705232,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nFWN3PU0YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518445387","title":"Protagonist Therapeutics Soars as Icotrokinra Drives Breakthrough Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2518445387","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518445387?lang=en_us&edition=fundamental","pubTime":"2025-03-11 21:29","pubTimestamp":1741699755,"startTime":"0","endTime":"0","summary":"March 11, 2025 - The stock of Protagonist Therapeutics  dramatically increased by 45.82% on Monday after it declared successful results from the Phase 2b ANTHEM-UC study of icotrokinra .GuruFocus has detected 5 Warning Signs with PTGX.The joint development project of Protagonist Therapeutics and Johnson & Johnson  produced Icotrokinra as their first-in-class targeted oral peptide. Icotrokinra is a pill taken orally to treat plaque psoriasis , and ulcerative colitis.Icotrokinra works by blocking the IL-23 receptor selectively and the study achieved a 63.5% clinical response at its highest dose after twelve weeks and the result is only 27% to placebo. The treatment presented a good safety outcome and showed improvement until Week 28.PTGX stands as an interesting investment material since it successfully turned around in 2024.In the biotech industry, it is quite common that in the first years the companies often face financial losses for the high cost of initial research and developments ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagonist-therapeutics-soars-icotrokinra-drives-132915786.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0795875086.SGD","LU0345769128.USD","IE00BSNM7G36.USD","BK4533","LU1718418525.SGD","LU1061106388.HKD","LU0889566641.SGD","LU1732800096.USD","PTGX","IE0002141913.USD","SG9999002232.USD","LU0122379950.USD","LU1585245621.USD","LU2089984988.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","JNJ","LU1929549753.HKD","IE0034235303.USD","LU1244550221.USD","LU2129689514.USD","LU1066051811.HKD","BK4550","LU2129689605.HKD","LU0882574055.USD","BK4139","BK4534","LU2468319806.SGD","LU0234572021.USD","IE00B4R5TH58.HKD","LU1244550577.SGD","LU2430703095.HKD","LU0203347892.USD","LU0792757196.USD","BK4504","LU1066051498.USD","IE00BDGV0183.EUR","LU1894683264.USD","BK4588","LU1221951129.SGD","LU0345770993.USD","LU2129689431.USD","BK4592","IE000M9KFDE8.USD","LU0098860793.USD","IE00B1BXHZ80.USD","LU1506573853.SGD","LU2505996509.AUD","LU1162221912.USD","LU2592432038.USD"],"gpt_icon":0},{"id":"2518771405","title":"Why Protagonist Therapeutics, Inc. (PTGX) Went Up on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2518771405","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518771405?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:47","pubTimestamp":1741690066,"startTime":"0","endTime":"0","summary":"The stock market suffered a bloodbath anew on Monday, with the Nasdaq plunging to its worst level in three years over concerns about the health of the US economy after the Trump administration acknowledged the possibility of a potential rough patch.The tech-heavy Nasdaq fell the heaviest, down 4 percent, followed by the S&P 500, which declined by 2.7 percent. The Dow Jones, for its part, dropped by 2.08 percent.Meanwhile, 10 companies managed to book modest gains, bucking the broader market caution. We have identified the names that led the charge and detailed the reasons behind their performance.To come up with the list, we considered only the stocks with $2 billion in market capitalization and $5 million in trading volume.Protagonist Therapeutics, Inc. surged by 45.89 percent on Monday to finish at $55.95 each as investor sentiment was buoyed by the positive result from the phase 2b study of icotrokinra , a drug candidate which it partnered with pharmaceutical giant Johnson & Johnson","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-protagonist-therapeutics-inc-ptgx-104746328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","SQQQ","PSQ","QID",".IXIC","TSYW.SI","USJW.SI","NQmain","TQQQ","PTGX","MNQmain","BK4139","USAW.SI","QLD"],"gpt_icon":1},{"id":"2518719628","title":"Protagonist Therapeutics price target raised to $80 from $54 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2518719628","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518719628?lang=en_us&edition=fundamental","pubTime":"2025-03-11 18:15","pubTimestamp":1741688140,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Protagonist Therapeutics (PTGX) to $80 from $54 and keeps a Buy rating on the shares. The firm sa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-therapeutics-price-target-raised-to-80-from-54-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-therapeutics-price-target-raised-to-80-from-54-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2518520936","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2518520936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518520936?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:28","pubTimestamp":1741631308,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) said Monday that lorundrostat met primary endpoints in phase 3 Launch-HTN and phase 2 Advance-HTN trials in patients with uncontrolled hypertension or resistant hypertens","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","LU0345770308.USD","BK4532","LU1674673428.USD","IE00BGHQF631.EUR","LU0640476718.USD","LU0203347892.USD","RKT","BK4559","LU0795875086.SGD","LU2347655156.SGD","BK4585","SG9999001440.SGD","LU1894683264.USD","LU1057294990.SGD","PTGX","BK7084","LU2430703251.USD","BK4581","IE00B2B36J28.USD","LU2592432038.USD","RKT.AU","BK4139","BK4533","BK4588","IE00B4R5TH58.HKD","RDFN","BK4007","LU1061106388.HKD","LU1244550494.USD","LU1732799900.SGD","IE00B19Z3581.USD","IE00B3PB1722.GBP","JNJ","IE000M9KFDE8.USD","LU1074936037.SGD","LU2129689431.USD","LU1196500208.SGD","LU1059921491.USD","LU1778281490.HKD","MLYS","LU1267930813.SGD","LU0289739699.SGD","BK4568","BK4079","LU1023059063.AUD","LU1674673691.USD","BK4592","LU0345769128.USD","IE00BJJMRZ35.SGD"],"gpt_icon":1},{"id":"2518272737","title":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272737","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518272737?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:12","pubTimestamp":1741623158,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Willis Lease Finance, CME Group Eikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKT","DXCM","LU0889565833.HKD","ADM","BK4607","IH","LU0048584097.USD","CBRL","LU0354030511.USD","MCHP","W","HUT","RKT","DASH","CKPT","REGN","SMC","FENC","EXE","NEM","WSM","BECN","FBIO","ABNB","MNDR","LU0289739699.SGD","ENPH","NOW","NOVA","CME","RDFN","STSS","TRVI","MLYS","SXTC","PRMB","TSYW.SI","TKO","WLFC","BKKT","PTGX","BK4599"],"gpt_icon":1},{"id":"2518494274","title":"Protagonist Therapeutics Inc : Btig Raises Target Price to $82 From $73","url":"https://stock-news.laohu8.com/highlight/detail?id=2518494274","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518494274?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:47","pubTimestamp":1741621643,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT14G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518222025","title":"Truist Securities Adjusts Price Target on Protagonist Therapeutics to $76 From $60, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222025","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518222025?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:53","pubTimestamp":1741614816,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) has an average rating of buy and mean price target of $59.91, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PTGX"],"gpt_icon":0},{"id":"2518226812","title":"Protagonist Therapeutics Shares Rise After Positive Trial Data for Icotronkinra","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226812","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226812?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:44","pubTimestamp":1741614240,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics shares were up 28% to $49.25 after the company reported positive topline results from a Phase 2b study of icotrokinra, conducted by partner Johnson & Johnson.The biopharmaceutical company said icotrokinra is a targeted oral peptide that selectively blocks the IL-23 receptor in adults with moderately to severely active ulcerative colitis.Protagonist said the study met its primary endpoint of clinical response in all icotrokinra dose groups evaluated. The study also demonstrated clinically meaningful differences versus placebo in key secondary endpoints of clinical remission, symptomatic remission and endoscopic improvement at week 12.Icotrokinra had a response rate of 63.5% for patients treated with the highest dose at week 12, versus 27% for placebo. Clinical remission and response rates continued to improve through week 28.Icotrokinra was well tolerated with the proportions of participants reporting one or more adverse events being similar between the icotroki","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0122379950.USD","BK4592","LU1221951129.SGD","LU1066051498.USD","LU0882574055.USD","LU0289739699.SGD","LU2430703095.HKD","SG9999002224.SGD","IE00B1BXHZ80.USD","LU1674673691.USD","LU1894683264.USD","PTGX","LU0345769128.USD","LU1914381329.SGD","LU1585245621.USD","LU0795875086.SGD","LU1244550494.USD","LU2347655156.SGD","LU2592432038.USD","BK4581","IE00B3PB1722.GBP","LU0889566641.SGD","LU2129689605.HKD","BK4532","JNJ","LU0345770308.USD","LU2430703251.USD","LU2129689431.USD","IE00B2B36J28.USD","BK4559","IE00B19Z3B42.SGD","LU1935042991.SGD","LU1221951046.USD","LU1674673428.USD","LU0912757837.SGD","LU1718418525.SGD","LU1032466523.USD","LU1732800096.USD","LU0058720904.USD","IE00B7SZLL34.SGD","BK4585","LU2112291526.USD","LU0640476718.USD","BK4139","LU0234572021.USD","IE00BDGV0183.EUR","LU0320765646.SGD","IE0009355771.USD","IE00B42XCP33.USD","LU1430594728.SGD"],"gpt_icon":0},{"id":"2518224920","title":"BUZZ-Protagonist Therapeutics rises as bowel disease drug succeeds mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518224920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518224920?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:38","pubTimestamp":1741613898,"startTime":"0","endTime":"0","summary":"BUZZ-Protagonist Therapeutics rises as bowel disease drug succeeds mid-stage study ** Drug developer Protagonist Therapeutics' PTGX.O shares rise 30.4% to $50.02** PTGX says the mid-stage study of all three doses of once-daily experimental drug, icotrokinra, conducted by its collaboration partner Johnson & Johnson JNJ.N met its main goal in patients with ulcerative colitis** Ulcerative colitis, a form of inflammatory bowel disease , is a condition in which the lining of the large intestine  and rectum become inflamed** Co says the study showed significant improvements over placebo in clinical recovery, symptom relief, and showed reduction in signs of disease severity within 12 weeks** Co says the study achieved a response rate of 63.5% vs 27% for placebo** PTGX had risen 24.2% in the past 12 months, as of last close  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nL4N3PT0Y0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0345769128.USD","LU1059921491.USD","LU0466842654.USD","LU2505996681.GBP","LU1057294990.SGD","LU1674673691.USD","LU1718418525.SGD","LU0889566641.SGD","PTGX","IE0002141913.USD","LU0795875169.SGD","SG9999002224.SGD","JNJ","LU1732799900.SGD","IE0034235303.USD","LU0058720904.USD","LU2129689514.USD","LU1066051811.HKD","IE00BJT1NW94.SGD","LU0882574055.USD","BK4139","BK4534","LU1430594728.SGD","IE00B3PB1722.GBP","LU1280957306.USD","LU2602419157.SGD","LU1244550577.SGD","LU0345769631.USD","BK4007","IE00BVYPNV92.GBP","LU1935042991.SGD","BK4504","BK4559","BK4532","LU0912757837.SGD","IE00B19Z3B42.SGD","LU0320765646.SGD","IE00BDGV0183.EUR","BK4588","LU1221951129.SGD","LU1674673428.USD","LU1162221912.USD","LU1894683348.USD","LU0345770993.USD","BK4592","LU1506573853.SGD","SG9999001440.SGD","BK4585","LU2592432038.USD"],"gpt_icon":0},{"id":"2518220457","title":"Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220457","media":"Blockhead","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220457?lang=en_us&edition=fundamental","pubTime":"2025-03-10 21:37","pubTimestamp":1741613866,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics broke out Monday after the company's drug topped its rival from Bristol in a psoriasis study.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2021/02/Stock-drugTest-09-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2021/02/Stock-drugTest-09-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/protagonist-therapeutics-bristol-myers-squibb-plaque-psoriasis/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4534","IE00BFTCPJ56.SGD","BK4588","LU0096364046.USD","IE0002141913.USD","LU2125154935.USD","LU0985481810.HKD","LU0225284248.USD","JNJ","IE0002270589.USD","LU0792757196.USD","LU0889566641.SGD","LU2242652126.USD","IE00BGHQF631.EUR","LU1162221912.USD","LU1291159041.SGD","PTGX","BK4139","BK4585","BK4533","LU0061475181.USD","LU0345770993.USD","BK4504","LU1059921491.USD","LU1674673428.USD","IE00B19Z3B42.SGD","LU0203347892.USD","LU1244550494.USD","LU2347655156.SGD","LU2430703178.SGD","LU1023059063.AUD","LU1066051811.HKD","LU1221951129.SGD","LU1732799900.SGD","IE00B4R5TH58.HKD","BK4592","LU1989771016.USD","LU0321505439.SGD","LU1506573853.SGD","LU2242646821.SGD","LU1244550221.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU0234570918.USD","LU2112291526.USD","IE0034235303.USD","BMY","LU1778281490.HKD","LU1267930813.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2518846225","title":"Protagonist Reports Positive Top Line Results From Phase 2B Study of Icotrokinra","url":"https://stock-news.laohu8.com/highlight/detail?id=2518846225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518846225?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:22","pubTimestamp":1741609335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518819225","title":"Protagonist : Results From Phase 2B Study of Icotrokinra Showing Potential to Transform Treatment Paradigm for Patients With Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2518819225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518819225?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:22","pubTimestamp":1741609335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518258422","title":"Protagonist Therapeutics : All Three Doses Met the Primary Endpoint of Clinical Response at Week 12, With a Favorable Safety Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2518258422","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518258422?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:22","pubTimestamp":1741609335,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTGX","BK4139"],"gpt_icon":0},{"id":"2518226539","title":"Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2518226539","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518226539?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:15","pubTimestamp":1741608900,"startTime":"0","endTime":"0","summary":"Clinical response rate of 63.5% and clinical remission rate of 30.2% achieved at Week 12 with the highest dose, which continued to improve through Week 28. All three doses met the primary endpoint of clinical response at Week 12, with a favorable safety profile. These results in ulcerative colitis build on strong data recently reported for the plaque psoriasis Phase 3 program. NEWARK, CALIFORNIA / ACCESS Newswire / March 10, 2025 / Protagonist Therapeutics, Inc.  today announced positive topline results from ANTHEM-UC, a Phase 2b study of icotrokinra , the first investigational targeted oral peptide that selectively blocks the IL-23 receptor, in adults with moderately to severely active ulcerative colitis . The study conducted by Protagonist's collaboration partner, Johnson & Johnson, met its primary endpoint of clinical responsea in all icotrokinra dose groups evaluated. Additionally, the study demonstrated clinically meaningful differences versus placebo in key secondary endpoints of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/protagonist-reports-positive-top-line-121500609.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1244550221.USD","LU0466842654.USD","IE00B42XCP33.USD","LU2129689514.USD","BK4585","LU2602419157.SGD","LU1261432733.SGD","LU1066051811.HKD","LU0203345920.USD","LU0345769631.USD","LU1894683264.USD","LU1059921491.USD","BK4504","LU2129689431.USD","IE00B4R5TH58.HKD","LU0058720904.USD","IE00BJT1NW94.SGD","BK4007","LU1023059063.AUD","LU1244550494.USD","JNJ","LU1914381329.SGD","IE000M9KFDE8.USD","LU0203347892.USD","LU0889566641.SGD","LU0122379950.USD","IE00B19Z3B42.SGD","LU2592432038.USD","IE0002270589.USD","PTGX","LU1674673691.USD","LU0289739699.SGD","LU0114720955.EUR","IE00BVYPNV92.GBP","IE00B19Z3581.USD","LU2347655156.SGD","BK4588","BK4581","LU0320765646.SGD","IE00BJJMRZ35.SGD","BK4139","LU1066051498.USD","LU1894683348.USD","BK4592","IE0009355771.USD","LU0345770993.USD","LU1032466523.USD","LU1057294990.SGD","LU0345769128.USD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2518624799","title":"Protagonist Therapeutics Price Target Maintained With a $54.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2518624799","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518624799?lang=en_us&edition=fundamental","pubTime":"2025-03-10 19:27","pubTimestamp":1741606020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PTGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 10, 2025 07:27 ET (11:27 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTGX"],"gpt_icon":0},{"id":"2518266971","title":"Protagonist Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Market Potential of Icotrokinra","url":"https://stock-news.laohu8.com/highlight/detail?id=2518266971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518266971?lang=en_us&edition=fundamental","pubTime":"2025-03-10 12:35","pubTimestamp":1741581334,"startTime":"0","endTime":"0","summary":"Jonathan Wolleben, an analyst from JMP Securities, reiterated the Buy rating on Protagonist Therapeutics (PTGX – Research Report). The associated p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-buy-rating-backed-by-promising-phase-3-results-and-market-potential-of-icotrokinra?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/protagonist-therapeutics-buy-rating-backed-by-promising-phase-3-results-and-market-potential-of-icotrokinra?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTGX"],"gpt_icon":0},{"id":"2518230558","title":"Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), Halozyme (HALO) and Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518230558","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518230558?lang=en_us&edition=fundamental","pubTime":"2025-03-10 08:21","pubTimestamp":1741566079,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Protagonist Therapeutics (PTGX – Research Report), H...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-protagonist-therapeutics-ptgx-halozyme-halo-and-arcturus-therapeutics-arct?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-protagonist-therapeutics-ptgx-halozyme-halo-and-arcturus-therapeutics-arct?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","PTGX","ARCT","LU0053671581.USD","HALO","HCSG","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":129,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"PTGX","fiscalQuarterEnding":"2025/03","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2025-02-21","symbol":"PTGX","fiscalQuarterEnding":"2024/12","expectedEps":0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740114000000,"reportTimeType":"pre","actualEps":1.98},{"market":"US","date":"2024-11-07","symbol":"PTGX","fiscalQuarterEnding":"2024/09","expectedEps":-0.59,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2024-08-06","symbol":"PTGX","fiscalQuarterEnding":"2024/06","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722916800000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-05-07","symbol":"PTGX","fiscalQuarterEnding":"2024/03","expectedEps":2.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"post","actualEps":3.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.6,"hold":0.1,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1733457600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PTGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PTGX","date":"2025-05-09","current":48.444601,"percent":1,"low":-33.150526,"twenty":-15.379737,"median":-8.271113,"eighty":-2.915413,"high":48.444601,"avg":-6.746948,"sd":11.845391,"marketCap":2722247463},"quantilePoints":[{"date":"2020-05-15","current":-6.707737,"twenty":-9.449125,"median":-6.436152,"eighty":-4.732566,"marketCap":557842221},{"date":"2020-05-22","current":-6.558676,"twenty":-9.437297,"median":-6.450252,"eighty":-4.737728,"marketCap":545445727},{"date":"2020-05-29","current":-6.844376,"twenty":-9.404895,"median":-6.539813,"eighty":-4.739024,"marketCap":569205673},{"date":"2020-06-05","current":-6.645628,"twenty":-9.379081,"median":-6.581449,"eighty":-4.739913,"marketCap":552677015},{"date":"2020-06-12","current":-6.699456,"twenty":-9.369673,"median":-6.614018,"eighty":-4.746872,"marketCap":557153526},{"date":"2020-06-19","current":-7.221168,"twenty":-9.365493,"median":-6.624925,"eighty":-4.756206,"marketCap":600541255},{"date":"2020-06-26","current":-7.676632,"twenty":-9.359153,"median":-6.653909,"eighty":-4.76292,"marketCap":638419430},{"date":"2020-07-02","current":-7.349526,"twenty":-9.350483,"median":-6.665119,"eighty":-4.765699,"marketCap":611216013},{"date":"2020-07-10","current":-6.745002,"twenty":-9.340032,"median":-6.693722,"eighty":-4.773141,"marketCap":560941344},{"date":"2020-07-17","current":-6.844376,"twenty":-9.31652,"median":-6.693867,"eighty":-4.786321,"marketCap":569205673},{"date":"2020-07-24","current":-6.409615,"twenty":-9.287585,"median":-6.699456,"eighty":-4.791108,"marketCap":533049233},{"date":"2020-07-31","current":-6.51313,"twenty":-9.266951,"median":-6.696733,"eighty":-4.791108,"marketCap":541657909},{"date":"2020-08-07","current":-9.004942,"twenty":-9.227278,"median":-6.701526,"eighty":-4.792704,"marketCap":661061766},{"date":"2020-08-14","current":-7.866789,"twenty":-9.208129,"median":-6.711877,"eighty":-4.798289,"marketCap":577508859},{"date":"2020-08-21","current":-10.519136,"twenty":-9.266951,"median":-6.719534,"eighty":-4.805114,"marketCap":772220259},{"date":"2020-08-28","current":-11.180969,"twenty":-9.350483,"median":-6.73258,"eighty":-4.808526,"marketCap":820806090},{"date":"2020-09-04","current":-10.288497,"twenty":-9.381064,"median":-6.745002,"eighty":-4.811454,"marketCap":755288832},{"date":"2020-09-11","current":-9.972622,"twenty":-9.453356,"median":-6.771156,"eighty":-4.817284,"marketCap":732100140},{"date":"2020-09-18","current":-11.030552,"twenty":-9.502467,"median":-6.779905,"eighty":-4.826262,"marketCap":809763856},{"date":"2020-09-25","current":-10.012733,"twenty":-9.579365,"median":-6.812626,"eighty":-4.827262,"marketCap":735044736},{"date":"2020-10-02","current":-10.283483,"twenty":-9.720678,"median":-6.825377,"eighty":-4.832331,"marketCap":754920758},{"date":"2020-10-09","current":-10.599358,"twenty":-9.834076,"median":-6.831954,"eighty":-4.838822,"marketCap":778109450},{"date":"2020-10-16","current":-10.438913,"twenty":-9.890916,"median":-6.842306,"eighty":-4.842911,"marketCap":766331067},{"date":"2020-10-23","current":-10.002705,"twenty":-9.954868,"median":-6.848516,"eighty":-4.844301,"marketCap":734308587},{"date":"2020-10-30","current":-9.501316,"twenty":-9.954868,"median":-6.855538,"eighty":-4.84986,"marketCap":697501139},{"date":"2020-11-06","current":-12.570131,"twenty":-9.996688,"median":-6.883005,"eighty":-4.85125,"marketCap":814104533},{"date":"2020-11-13","current":-13.119484,"twenty":-10.043212,"median":-6.902064,"eighty":-4.857232,"marketCap":849683350},{"date":"2020-11-20","current":-12.835947,"twenty":-10.069639,"median":-6.909829,"eighty":-4.859892,"marketCap":831320090},{"date":"2020-11-27","current":-14.088234,"twenty":-10.133066,"median":-6.931328,"eighty":-4.863756,"marketCap":912424489},{"date":"2020-12-04","current":-13.23467,"twenty":-10.191167,"median":-6.947788,"eighty":-4.866904,"marketCap":857143424},{"date":"2020-12-11","current":-12.711899,"twenty":-10.248386,"median":-6.951835,"eighty":-4.870704,"marketCap":823286163},{"date":"2020-12-18","current":-14.028485,"twenty":-10.288497,"median":-6.96474,"eighty":-4.870704,"marketCap":908554859},{"date":"2020-12-24","current":-15.775404,"twenty":-10.372775,"median":-6.983794,"eighty":-4.874047,"marketCap":1021694030},{"date":"2020-12-31","current":-13.390827,"twenty":-10.427646,"median":-7.004819,"eighty":-4.876544,"marketCap":867256911},{"date":"2021-01-08","current":-13.716298,"twenty":-10.516128,"median":-7.024491,"eighty":-4.884694,"marketCap":888336072},{"date":"2021-01-15","current":-16.187225,"twenty":-10.554233,"median":-7.0866,"eighty":-4.894853,"marketCap":1048365621},{"date":"2021-01-22","current":-14.852128,"twenty":-10.591336,"median":-7.135435,"eighty":-4.901178,"marketCap":961898042},{"date":"2021-01-29","current":-13.756152,"twenty":-10.619413,"median":-7.158325,"eighty":-4.905297,"marketCap":890917194},{"date":"2021-02-05","current":-14.865412,"twenty":-10.704851,"median":-7.200905,"eighty":-4.911244,"marketCap":962758416},{"date":"2021-02-12","current":-17.362908,"twenty":-10.770833,"median":-7.218551,"eighty":-4.922482,"marketCap":1124508713},{"date":"2021-02-19","current":-17.024152,"twenty":-10.799869,"median":-7.241871,"eighty":-4.92629,"marketCap":1102569178},{"date":"2021-02-26","current":-15.655843,"twenty":-10.882835,"median":-7.247939,"eighty":-4.927782,"marketCap":1013950664},{"date":"2021-03-05","current":-19.342306,"twenty":-10.94369,"median":-7.26205,"eighty":-4.93554,"marketCap":1252704427},{"date":"2021-03-12","current":-20.52997,"twenty":-11.026541,"median":-7.301179,"eighty":-4.944648,"marketCap":1358057548},{"date":"2021-03-19","current":-20.629309,"twenty":-11.096898,"median":-7.312261,"eighty":-4.952769,"marketCap":1364628794},{"date":"2021-03-26","current":-18.020016,"twenty":-11.193984,"median":-7.333401,"eighty":-4.954083,"marketCap":1192024060},{"date":"2021-04-01","current":-17.688887,"twenty":-11.231108,"median":-7.344739,"eighty":-4.954083,"marketCap":1170119906},{"date":"2021-04-09","current":-17.602794,"twenty":-11.41166,"median":-7.360757,"eighty":-4.954083,"marketCap":1164424826},{"date":"2021-04-16","current":-17.63548,"twenty":-11.516633,"median":-7.38668,"eighty":-4.961031,"marketCap":1166586981},{"date":"2021-04-23","current":-19.309356,"twenty":-11.594149,"median":-7.421229,"eighty":-4.962647,"marketCap":1277313881},{"date":"2021-04-30","current":-19.223005,"twenty":-11.691477,"median":-7.444978,"eighty":-4.963904,"marketCap":1271601779},{"date":"2021-05-07","current":-18.301078,"twenty":-11.75763,"median":-7.473566,"eighty":-4.967979,"marketCap":1282319943},{"date":"2021-05-14","current":-19.110139,"twenty":-11.88162,"median":-7.483013,"eighty":-4.967979,"marketCap":1339009208},{"date":"2021-05-21","current":-21.49969,"twenty":-11.947151,"median":-7.506443,"eighty":-4.974928,"marketCap":1506440290},{"date":"2021-05-28","current":-22.020249,"twenty":-11.985902,"median":-7.534801,"eighty":-4.976672,"marketCap":1542914778},{"date":"2021-06-04","current":-21.832095,"twenty":-12.059638,"median":-7.548308,"eighty":-4.980835,"marketCap":1529731228},{"date":"2021-06-11","current":-24.861369,"twenty":-12.389994,"median":-7.587616,"eighty":-4.993626,"marketCap":1741986380},{"date":"2021-06-18","current":-28.48276,"twenty":-12.537035,"median":-7.597798,"eighty":-4.997154,"marketCap":1995730024},{"date":"2021-06-25","current":-29.247308,"twenty":-12.582661,"median":-7.600475,"eighty":-5.001637,"marketCap":2049300361},{"date":"2021-07-02","current":-31.091612,"twenty":-12.701939,"median":-7.651717,"eighty":-5.008279,"marketCap":2178527052},{"date":"2021-07-09","current":-30.9776,"twenty":-12.711899,"median":-7.67129,"eighty":-5.009669,"marketCap":2170538493},{"date":"2021-07-16","current":-30.729458,"twenty":-12.777141,"median":-7.687868,"eighty":-5.009724,"marketCap":2153151629},{"date":"2021-07-23","current":-31.534245,"twenty":-12.933061,"median":-7.7092,"eighty":-5.010215,"marketCap":2209541458},{"date":"2021-07-30","current":-33.150526,"twenty":-13.021304,"median":-7.726424,"eighty":-5.012424,"marketCap":2322791031},{"date":"2021-08-06","current":-28.073213,"twenty":-13.121745,"median":-7.74057,"eighty":-5.014773,"marketCap":2287658067},{"date":"2021-08-13","current":-27.828134,"twenty":-13.235716,"median":-7.773558,"eighty":-5.021266,"marketCap":2267686826},{"date":"2021-08-20","current":-28.720922,"twenty":-13.296243,"median":-7.792145,"eighty":-5.029659,"marketCap":2340439203},{"date":"2021-08-27","current":-27.933168,"twenty":-13.451458,"median":-7.801258,"eighty":-5.035552,"marketCap":2276245929},{"date":"2021-09-03","current":-28.522525,"twenty":-13.634575,"median":-7.822739,"eighty":-5.041631,"marketCap":2324272008},{"date":"2021-09-10","current":-26.305143,"twenty":-13.708328,"median":-7.836668,"eighty":-5.045214,"marketCap":2143579830},{"date":"2021-09-17","current":-10.22913,"twenty":-13.764123,"median":-7.855229,"eighty":-5.050099,"marketCap":833561544},{"date":"2021-09-24","current":-10.976037,"twenty":-13.742868,"median":-7.871118,"eighty":-5.056692,"marketCap":894426278},{"date":"2021-10-01","current":-10.474209,"twenty":-13.720284,"median":-7.892183,"eighty":-5.058339,"marketCap":853532785},{"date":"2021-10-08","current":-10.64343,"twenty":-13.708328,"median":-7.896506,"eighty":-5.059985,"marketCap":867322451},{"date":"2021-10-15","current":-18.071657,"twenty":-13.815403,"median":-7.923511,"eighty":-5.063529,"marketCap":1472641245},{"date":"2021-10-22","current":-18.065822,"twenty":-14.044427,"median":-7.940329,"eighty":-5.065985,"marketCap":1472165740},{"date":"2021-10-29","current":-18.182526,"twenty":-14.108193,"median":-7.965498,"eighty":-5.06708,"marketCap":1481675854},{"date":"2021-11-05","current":-14.975824,"twenty":-14.259226,"median":-7.972706,"eighty":-5.068568,"marketCap":1610350378},{"date":"2021-11-12","current":-16.467193,"twenty":-14.433745,"median":-7.975682,"eighty":-5.071361,"marketCap":1770717221},{"date":"2021-11-19","current":-15.548403,"twenty":-14.860098,"median":-7.984462,"eighty":-5.076877,"marketCap":1671919791},{"date":"2021-11-26","current":-14.762772,"twenty":-15.018434,"median":-8.001658,"eighty":-5.084697,"marketCap":1587440830},{"date":"2021-12-03","current":-14.323351,"twenty":-14.965171,"median":-8.023507,"eighty":-5.090214,"marketCap":1540189885},{"date":"2021-12-10","current":-14.119175,"twenty":-15.004231,"median":-8.049664,"eighty":-5.09948,"marketCap":1518234900},{"date":"2021-12-17","current":-13.475579,"twenty":-14.965171,"median":-8.10968,"eighty":-5.100086,"marketCap":1449028971},{"date":"2021-12-23","current":-15.202193,"twenty":-14.975824,"median":-8.126854,"eighty":-5.100445,"marketCap":1634691774},{"date":"2021-12-31","current":-15.18,"twenty":-15.108982,"median":-8.143408,"eighty":-5.105061,"marketCap":1632305363},{"date":"2022-01-07","current":-15.472947,"twenty":-15.18,"median":-8.170847,"eighty":-5.105061,"marketCap":1663805993},{"date":"2022-01-14","current":-15.961193,"twenty":-15.310445,"median":-8.220609,"eighty":-5.107204,"marketCap":1716307042},{"date":"2022-01-21","current":-13.018403,"twenty":-15.313651,"median":-8.244628,"eighty":-5.11179,"marketCap":1399868897},{"date":"2022-01-28","current":-12.494649,"twenty":-15.270004,"median":-8.259405,"eighty":-5.112936,"marketCap":1343549590},{"date":"2022-02-04","current":-12.534596,"twenty":-15.220835,"median":-8.287857,"eighty":-5.134046,"marketCap":1347845130},{"date":"2022-02-11","current":-12.361491,"twenty":-15.203968,"median":-8.33787,"eighty":-5.153028,"marketCap":1329231121},{"date":"2022-02-18","current":-11.029912,"twenty":-15.202193,"median":-8.359941,"eighty":-5.157029,"marketCap":1186046440},{"date":"2022-02-25","current":-10.870123,"twenty":-15.188877,"median":-8.37967,"eighty":-5.160387,"marketCap":1168864279},{"date":"2022-03-04","current":-9.374147,"twenty":-15.178559,"median":-8.389798,"eighty":-5.170868,"marketCap":1176933522},{"date":"2022-03-11","current":-9.836877,"twenty":-15.098329,"median":-8.39452,"eighty":-5.173647,"marketCap":1235029788},{"date":"2022-03-18","current":-10.480844,"twenty":-14.876842,"median":-8.39452,"eighty":-5.173647,"marketCap":1315880424},{"date":"2022-03-25","current":-9.624793,"twenty":-14.566387,"median":-8.39452,"eighty":-5.173647,"marketCap":1208402332},{"date":"2022-04-01","current":-9.324018,"twenty":-14.424835,"median":-8.39452,"eighty":-5.173647,"marketCap":1170639759},{"date":"2022-04-08","current":-9.70577,"twenty":-14.310208,"median":-8.39452,"eighty":-5.173647,"marketCap":1218569179},{"date":"2022-04-14","current":-7.714908,"twenty":-14.18041,"median":-8.386442,"eighty":-5.173647,"marketCap":968614434},{"date":"2022-04-22","current":-7.312727,"twenty":-14.094448,"median":-8.352792,"eighty":-5.173647,"marketCap":918120248},{"date":"2022-04-29","current":-3.515214,"twenty":-14.033799,"median":-8.271595,"eighty":-5.134046,"marketCap":441338607},{"date":"2022-05-06","current":-3.614961,"twenty":-13.758809,"median":-8.235986,"eighty":-5.104138,"marketCap":442771319},{"date":"2022-05-13","current":-3.499759,"twenty":-13.724069,"median":-8.198163,"eighty":-5.081552,"marketCap":428661025},{"date":"2022-05-20","current":-3.146208,"twenty":-13.724069,"median":-8.198163,"eighty":-5.06468,"marketCap":385357016},{"date":"2022-05-27","current":-3.535512,"twenty":-13.724069,"median":-8.198163,"eighty":-5.046019,"marketCap":433040082},{"date":"2022-06-03","current":-3.654686,"twenty":-13.724069,"median":-8.178259,"eighty":-5.023191,"marketCap":447636938},{"date":"2022-06-10","current":-2.911832,"twenty":-13.724069,"median":-8.178259,"eighty":-5.009669,"marketCap":356649865},{"date":"2022-06-17","current":-3.122373,"twenty":-13.724069,"median":-8.178259,"eighty":-4.980835,"marketCap":382437645},{"date":"2022-06-24","current":-3.607016,"twenty":-13.725196,"median":-8.136316,"eighty":-4.966349,"marketCap":441798196},{"date":"2022-07-01","current":-3.122373,"twenty":-13.725196,"median":-8.111134,"eighty":-4.954083,"marketCap":382437645},{"date":"2022-07-08","current":-3.821531,"twenty":-13.725196,"median":-8.06172,"eighty":-4.930766,"marketCap":468072538},{"date":"2022-07-15","current":-3.757971,"twenty":-13.725196,"median":-7.987171,"eighty":-4.902518,"marketCap":460287547},{"date":"2022-07-22","current":-3.93276,"twenty":-13.725196,"median":-7.971801,"eighty":-4.870704,"marketCap":481696271},{"date":"2022-07-29","current":-3.952623,"twenty":-13.725196,"median":-7.937326,"eighty":-4.854029,"marketCap":484129080},{"date":"2022-08-05","current":-4.239613,"twenty":-13.725196,"median":-7.919184,"eighty":-4.835066,"marketCap":562503419},{"date":"2022-08-12","current":-4.217416,"twenty":-13.725196,"median":-7.896506,"eighty":-4.808704,"marketCap":559558375},{"date":"2022-08-19","current":-3.536711,"twenty":-13.725196,"median":-7.896506,"eighty":-4.791108,"marketCap":469243690},{"date":"2022-08-26","current":-3.451622,"twenty":-13.725196,"median":-7.89352,"eighty":-4.756206,"marketCap":457954354},{"date":"2022-09-02","current":-3.274047,"twenty":-13.725196,"median":-7.821543,"eighty":-4.731245,"marketCap":434394001},{"date":"2022-09-09","current":-3.270347,"twenty":-13.725196,"median":-7.786399,"eighty":-4.687787,"marketCap":433903161},{"date":"2022-09-16","current":-3.092772,"twenty":-13.725196,"median":-7.737759,"eighty":-4.625933,"marketCap":410342808},{"date":"2022-09-23","current":-3.077974,"twenty":-13.725196,"median":-7.700362,"eighty":-4.571699,"marketCap":408379445},{"date":"2022-09-30","current":-3.118668,"twenty":-13.725196,"median":-7.641433,"eighty":-4.473266,"marketCap":413778693},{"date":"2022-10-07","current":-3.074275,"twenty":-13.725196,"median":-7.556602,"eighty":-4.390662,"marketCap":407888605},{"date":"2022-10-14","current":-2.955891,"twenty":-13.725196,"median":-7.482881,"eighty":-4.270343,"marketCap":392181703},{"date":"2022-10-21","current":-3.052078,"twenty":-13.725196,"median":-7.389679,"eighty":-4.207058,"marketCap":404943561},{"date":"2022-10-28","current":-3.174161,"twenty":-13.725196,"median":-7.329698,"eighty":-4.07704,"marketCap":421141303},{"date":"2022-11-04","current":-2.915197,"twenty":-13.725196,"median":-7.297769,"eighty":-4.001892,"marketCap":386782455},{"date":"2022-11-11","current":-3.206636,"twenty":-13.725196,"median":-7.245724,"eighty":-3.947357,"marketCap":417202525},{"date":"2022-11-18","current":-3.055379,"twenty":-13.725196,"median":-7.201344,"eighty":-3.902686,"marketCap":397523160},{"date":"2022-11-25","current":-2.873871,"twenty":-13.725196,"median":-7.138357,"eighty":-3.883416,"marketCap":373907923},{"date":"2022-12-02","current":-3.051598,"twenty":-13.725196,"median":-7.024491,"eighty":-3.813471,"marketCap":397031176},{"date":"2022-12-09","current":-2.862527,"twenty":-13.725196,"median":-6.972734,"eighty":-3.760354,"marketCap":372431971},{"date":"2022-12-16","current":-3.667968,"twenty":-13.725196,"median":-6.94375,"eighty":-3.7496,"marketCap":477224586},{"date":"2022-12-23","current":-3.815443,"twenty":-13.725196,"median":-6.908816,"eighty":-3.718259,"marketCap":496411966},{"date":"2022-12-30","current":-4.125518,"twenty":-13.725196,"median":-6.883005,"eighty":-3.718259,"marketCap":536754664},{"date":"2023-01-06","current":-4.412905,"twenty":-13.725196,"median":-6.84859,"eighty":-3.718259,"marketCap":574145456},{"date":"2023-01-13","current":-4.601976,"twenty":-13.725196,"median":-6.833255,"eighty":-3.718259,"marketCap":598744661},{"date":"2023-01-20","current":-4.409124,"twenty":-13.725196,"median":-6.82294,"eighty":-3.718259,"marketCap":573653472},{"date":"2023-01-27","current":-5.101122,"twenty":-13.725196,"median":-6.776526,"eighty":-3.718259,"marketCap":663686564},{"date":"2023-02-03","current":-5.41876,"twenty":-13.725196,"median":-6.724299,"eighty":-3.718259,"marketCap":705013229},{"date":"2023-02-10","current":-6.507806,"twenty":-13.725196,"median":-6.707737,"eighty":-3.718259,"marketCap":846704653},{"date":"2023-02-17","current":-6.11454,"twenty":-13.725196,"median":-6.693722,"eighty":-3.718259,"marketCap":795538305},{"date":"2023-02-24","current":-6.379238,"twenty":-13.725196,"median":-6.663907,"eighty":-3.718259,"marketCap":829977193},{"date":"2023-03-03","current":-5.940595,"twenty":-13.725196,"median":-6.624925,"eighty":-3.718259,"marketCap":772907036},{"date":"2023-03-10","current":-9.453525,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1229960275},{"date":"2023-03-17","current":-9.023959,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1149589221},{"date":"2023-03-24","current":-8.343741,"twenty":-13.725196,"median":-6.621811,"eighty":-3.718259,"marketCap":1062934191},{"date":"2023-03-31","current":-9.257407,"twenty":-13.724069,"median":-6.653909,"eighty":-3.719583,"marketCap":1179328818},{"date":"2023-04-06","current":-7.686398,"twenty":-13.724069,"median":-6.682278,"eighty":-3.719583,"marketCap":979193321},{"date":"2023-04-14","current":-8.643758,"twenty":-13.725196,"median":-6.707737,"eighty":-3.718259,"marketCap":1101154213},{"date":"2023-04-21","current":-10.23871,"twenty":-13.725196,"median":-6.724299,"eighty":-3.718259,"marketCap":1304340024},{"date":"2023-04-28","current":-10.043772,"twenty":-13.725196,"median":-6.771156,"eighty":-3.718259,"marketCap":1279506203},{"date":"2023-05-05","current":-10.455801,"twenty":-13.725196,"median":-6.812626,"eighty":-3.718259,"marketCap":1331995870},{"date":"2023-05-12","current":-10.095379,"twenty":-13.725196,"median":-6.833255,"eighty":-3.718259,"marketCap":1415250998},{"date":"2023-05-19","current":-10.226064,"twenty":-13.725196,"median":-6.84859,"eighty":-3.718259,"marketCap":1433571400},{"date":"2023-05-26","current":-10.356748,"twenty":-13.726324,"median":-6.891609,"eighty":-3.716934,"marketCap":1451891801},{"date":"2023-06-02","current":-11.226617,"twenty":-13.726324,"median":-6.909323,"eighty":-3.716934,"marketCap":1573836972},{"date":"2023-06-09","current":-11.990305,"twenty":-13.726324,"median":-6.947793,"eighty":-3.716934,"marketCap":1680896817},{"date":"2023-06-16","current":-11.7126,"twenty":-13.727451,"median":-6.972734,"eighty":-3.71561,"marketCap":1641965964},{"date":"2023-06-23","current":-11.247036,"twenty":-13.728579,"median":-7.018276,"eighty":-3.714286,"marketCap":1576699535},{"date":"2023-06-30","current":-11.300127,"twenty":-13.734094,"median":-7.132514,"eighty":-3.713546,"marketCap":1584142198},{"date":"2023-07-07","current":-9.662487,"twenty":-13.734094,"median":-7.200466,"eighty":-3.713546,"marketCap":1354564669},{"date":"2023-07-14","current":-8.737485,"twenty":-13.734094,"median":-7.241871,"eighty":-3.713546,"marketCap":1224890579},{"date":"2023-07-21","current":-8.126943,"twenty":-13.734094,"median":-7.285773,"eighty":-3.713546,"marketCap":1139299954},{"date":"2023-07-28","current":-7.669548,"twenty":-13.734094,"median":-7.312727,"eighty":-3.713546,"marketCap":1075178550},{"date":"2023-08-04","current":-7.763453,"twenty":-13.734094,"median":-7.383681,"eighty":-3.713546,"marketCap":1068336593},{"date":"2023-08-11","current":-7.859608,"twenty":-13.734094,"median":-7.383681,"eighty":-3.713546,"marketCap":1081568549},{"date":"2023-08-18","current":-7.838705,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1078692037},{"date":"2023-08-25","current":-8.06446,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1109758368},{"date":"2023-09-01","current":-8.286034,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1140249396},{"date":"2023-09-08","current":-7.842886,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1079267339},{"date":"2023-09-15","current":-7.525157,"twenty":-13.734094,"median":-7.389679,"eighty":-3.713546,"marketCap":1035544356},{"date":"2023-09-22","current":-7.098731,"twenty":-13.734094,"median":-7.349526,"eighty":-3.713546,"marketCap":976863509},{"date":"2023-09-29","current":-7.161441,"twenty":-13.734094,"median":-7.312727,"eighty":-3.713546,"marketCap":985493045},{"date":"2023-10-06","current":-6.785183,"twenty":-13.734094,"median":-7.297769,"eighty":-3.713546,"marketCap":933715827},{"date":"2023-10-13","current":-6.425648,"twenty":-13.734094,"median":-7.241871,"eighty":-3.713546,"marketCap":884239819},{"date":"2023-10-19","current":-6.212435,"twenty":-13.734094,"median":-7.201344,"eighty":-3.713546,"marketCap":854899396},{"date":"2023-10-27","current":-5.940693,"twenty":-13.756152,"median":-7.161441,"eighty":-3.710587,"marketCap":817504738},{"date":"2023-11-03","current":-6.310619,"twenty":-13.756152,"median":-7.113513,"eighty":-3.710587,"marketCap":886541029},{"date":"2023-11-10","current":-6.174931,"twenty":-13.756152,"median":-7.024491,"eighty":-3.710587,"marketCap":867478954},{"date":"2023-11-17","current":-6.618343,"twenty":-13.756152,"median":-6.973312,"eighty":-3.710587,"marketCap":929771326},{"date":"2023-11-24","current":-7.074073,"twenty":-13.756152,"median":-7.012061,"eighty":-3.710587,"marketCap":993794042},{"date":"2023-12-01","current":-7.476429,"twenty":-13.756152,"median":-7.074073,"eighty":-3.710587,"marketCap":1050318601},{"date":"2023-12-08","current":-8.58496,"twenty":-13.750637,"median":-7.12048,"eighty":-3.711327,"marketCap":1206049531},{"date":"2023-12-15","current":-8.527481,"twenty":-13.750637,"median":-7.155703,"eighty":-3.711327,"marketCap":1197974593},{"date":"2023-12-22","current":-8.872357,"twenty":-13.750637,"median":-7.200905,"eighty":-3.711327,"marketCap":1246424216},{"date":"2023-12-29","current":-9.496419,"twenty":-13.756152,"median":-7.221168,"eighty":-3.710587,"marketCap":1334094961},{"date":"2024-01-05","current":-9.369143,"twenty":-13.758809,"median":-7.255861,"eighty":-3.710382,"marketCap":1316214744},{"date":"2024-01-12","current":-10.026051,"twenty":-13.758809,"median":-7.308825,"eighty":-3.710382,"marketCap":1408499739},{"date":"2024-01-19","current":-9.83719,"twenty":-13.761466,"median":-7.337105,"eighty":-3.710177,"marketCap":1381967803},{"date":"2024-01-26","current":-9.9891,"twenty":-13.758809,"median":-7.381258,"eighty":-3.710382,"marketCap":1403308708},{"date":"2024-02-02","current":-11.709376,"twenty":-13.758809,"median":-7.448718,"eighty":-3.710382,"marketCap":1644980039},{"date":"2024-02-09","current":-10.719909,"twenty":-13.758809,"median":-7.506951,"eighty":-3.710382,"marketCap":1505975765},{"date":"2024-02-16","current":-11.590312,"twenty":-13.758809,"median":-7.588064,"eighty":-3.710382,"marketCap":1628253384},{"date":"2024-02-23","current":-11.368606,"twenty":-13.758809,"median":-7.612358,"eighty":-3.710382,"marketCap":1597107198},{"date":"2024-03-01","current":-22.422829,"twenty":-13.846047,"median":-7.669548,"eighty":-3.710587,"marketCap":1770394439},{"date":"2024-03-08","current":-22.799249,"twenty":-14.088234,"median":-7.709105,"eighty":-3.710587,"marketCap":1800114688},{"date":"2024-03-15","current":-20.924529,"twenty":-14.167973,"median":-7.750912,"eighty":-3.710587,"marketCap":1652096193},{"date":"2024-03-22","current":-20.924529,"twenty":-14.310035,"median":-7.763453,"eighty":-3.710587,"marketCap":1652096193},{"date":"2024-03-28","current":-21.020479,"twenty":-14.42038,"median":-7.763453,"eighty":-3.710587,"marketCap":1659671943},{"date":"2024-04-05","current":-20.407874,"twenty":-14.566387,"median":-7.825595,"eighty":-3.710382,"marketCap":1611303694},{"date":"2024-04-12","current":-20.415255,"twenty":-14.876842,"median":-7.865289,"eighty":-3.710382,"marketCap":1611886444},{"date":"2024-04-19","current":-18.614343,"twenty":-15.098329,"median":-7.910185,"eighty":-3.710382,"marketCap":1469695449},{"date":"2024-04-26","current":-18.201019,"twenty":-15.18,"median":-7.996259,"eighty":-3.710587,"marketCap":1437061450},{"date":"2024-05-03","current":-18.969611,"twenty":-15.310445,"median":-8.088174,"eighty":-3.710587,"marketCap":1497745616},{"date":"2024-05-10","current":10.228214,"twenty":-15.330912,"median":-8.126943,"eighty":-3.694411,"marketCap":1658095799},{"date":"2024-05-17","current":11.556037,"twenty":-15.330912,"median":-8.126943,"eighty":-3.654686,"marketCap":1873349128},{"date":"2024-05-24","current":11.04951,"twenty":-15.330912,"median":-8.126943,"eighty":-3.622906,"marketCap":1791236141},{"date":"2024-05-31","current":10.025604,"twenty":-15.330912,"median":-8.126943,"eighty":-3.603684,"marketCap":1625250605},{"date":"2024-06-07","current":12.30859,"twenty":-15.330912,"median":-8.126943,"eighty":-3.535512,"marketCap":1995345564},{"date":"2024-06-14","current":12.427986,"twenty":-15.332132,"median":-8.135111,"eighty":-3.509824,"marketCap":2014700768},{"date":"2024-06-21","current":11.371517,"twenty":-15.333353,"median":-8.143279,"eighty":-3.48069,"marketCap":1843436540},{"date":"2024-06-28","current":11.534329,"twenty":-15.337014,"median":-8.157491,"eighty":-3.42031,"marketCap":1869830000},{"date":"2024-07-05","current":12.482256,"twenty":-15.337014,"median":-8.157491,"eighty":-3.39613,"marketCap":2023498588},{"date":"2024-07-12","current":12.948984,"twenty":-15.337014,"median":-8.157491,"eighty":-3.360722,"marketCap":2099159840},{"date":"2024-07-15","current":13.06838,"twenty":-15.337014,"median":-8.157491,"eighty":-3.35675,"marketCap":2118515043},{"date":"2024-08-02","current":13.7341,"twenty":-15.368196,"median":-8.262741,"eighty":-3.343328,"marketCap":2226434968},{"date":"2024-08-09","current":12.886266,"twenty":-15.368196,"median":-8.262741,"eighty":-3.288729,"marketCap":2190072470},{"date":"2024-08-16","current":14.068143,"twenty":-15.368196,"median":-8.262741,"eighty":-3.264428,"marketCap":2390937105},{"date":"2024-08-23","current":14.362745,"twenty":-15.368196,"median":-8.262741,"eighty":-3.236958,"marketCap":2441006002},{"date":"2024-08-30","current":14.657348,"twenty":-15.368196,"median":-8.262741,"eighty":-3.21123,"marketCap":2491074899},{"date":"2024-09-06","current":14.563768,"twenty":-15.368196,"median":-8.262741,"eighty":-3.182376,"marketCap":2475170661},{"date":"2024-09-13","current":15.821895,"twenty":-15.368196,"median":-8.262741,"eighty":-3.169466,"marketCap":2688994305},{"date":"2024-09-20","current":15.915474,"twenty":-15.368196,"median":-8.262741,"eighty":-3.139194,"marketCap":2704898543},{"date":"2024-09-27","current":15.572349,"twenty":-15.368196,"median":-8.262741,"eighty":-3.125331,"marketCap":2646583004},{"date":"2024-10-04","current":15.36786,"twenty":-15.368196,"median":-8.262741,"eighty":-3.113634,"marketCap":2611829298},{"date":"2024-10-11","current":15.107917,"twenty":-15.368196,"median":-8.262741,"eighty":-3.099754,"marketCap":2567650860},{"date":"2024-10-18","current":16.296725,"twenty":-15.368196,"median":-8.262741,"eighty":-3.090553,"marketCap":2769693586},{"date":"2024-10-25","current":16.272464,"twenty":-15.368196,"median":-8.262741,"eighty":-3.084958,"marketCap":2765570265},{"date":"2024-10-31","current":16.50468,"twenty":-15.368196,"median":-8.262741,"eighty":-3.065396,"marketCap":2805036337},{"date":"2024-11-08","current":16.414771,"twenty":-15.371747,"median":-8.266026,"eighty":-3.052078,"marketCap":2804447291},{"date":"2024-11-15","current":14.316166,"twenty":-15.371747,"median":-8.266026,"eighty":-3.040652,"marketCap":2445902658},{"date":"2024-11-22","current":14.528955,"twenty":-15.371747,"median":-8.266026,"eighty":-3.023767,"marketCap":2482257449},{"date":"2024-11-29","current":15.278949,"twenty":-15.371747,"median":-8.266026,"eighty":-3.003662,"marketCap":2610393188},{"date":"2024-12-06","current":14.53942,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2484045390},{"date":"2024-12-13","current":14.085935,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2406567966},{"date":"2024-12-20","current":13.792914,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2356505631},{"date":"2024-12-27","current":13.782449,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2354717691},{"date":"2025-01-03","current":13.597567,"twenty":-15.371747,"median":-8.266026,"eighty":-2.993626,"marketCap":2323130741},{"date":"2025-01-10","current":13.123152,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2242077437},{"date":"2025-01-17","current":12.746411,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2177711577},{"date":"2025-01-24","current":13.185942,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2252805080},{"date":"2025-01-31","current":13.646404,"twenty":-15.375298,"median":-8.269311,"eighty":-2.996585,"marketCap":2331474464},{"date":"2025-02-07","current":13.168501,"twenty":-15.375298,"median":-8.269311,"eighty":-2.991095,"marketCap":2249825179},{"date":"2025-02-14","current":13.492917,"twenty":-15.375298,"median":-8.269311,"eighty":-2.95959,"marketCap":2305251336},{"date":"2025-02-21","current":13.426638,"twenty":-15.375298,"median":-8.269311,"eighty":-2.9495,"marketCap":2293927712},{"date":"2025-02-28","current":8.106113,"twenty":-15.375298,"median":-8.269311,"eighty":-2.939639,"marketCap":2230705062},{"date":"2025-03-07","current":8.710614,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2397056485},{"date":"2025-03-14","current":12.246164,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3369997466},{"date":"2025-03-21","current":11.833498,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3256436531},{"date":"2025-03-28","current":11.02824,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":3034839248},{"date":"2025-04-04","current":10.372434,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2854369438},{"date":"2025-04-11","current":9.12105,"twenty":-15.375298,"median":-8.269311,"eighty":-2.915804,"marketCap":2510003577},{"date":"2025-04-17","current":10.21629,"twenty":-15.375298,"median":-8.269311,"eighty":-2.915804,"marketCap":2811400436},{"date":"2025-04-25","current":10.00438,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2753085361},{"date":"2025-05-02","current":10.035609,"twenty":-15.379737,"median":-8.271113,"eighty":-2.92461,"marketCap":2761679162},{"date":"2025-05-09","current":48.444601,"twenty":-15.379737,"median":-8.271113,"eighty":-2.915413,"marketCap":2722247463}],"updateTime":1746941228268}}}